Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury
NCT ID: NCT02114138
Last Updated: 2025-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
240 participants
OBSERVATIONAL
2015-07-31
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Prediction of Acute Kidney Injury in High Risk Patients After Non-cardiac Surgery
NCT03880110
Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery
NCT05068167
Biomarkers of Acute Kidney Injury Following Cardiac Surgery
NCT04387149
Preoperative Inflammatory Status and Postoperative Acute Kidney Injury
NCT06027476
Prognostic Significance of Preoperative Nutritional Status on Postoperative Acute Kidney Injury
NCT06496802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study participants will complete telephone interviews at 6 and 12 months after discharge from the hospital with a study team member. The telephone interview will consist of a short questionnaire asking about state of health and a health survey.
At the same times of the phone interviews, the study team will mail a urine dipstick that is used to detect any amount of protein in the urine. Study participants will be asked to urinate on dipstick and send it back to the study team in provided shipping material.
Healthy Controls will be enrolled to establish baseline values for kidney health based upon a single urine collection and a brief health questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical Group
Adults undergoing major in hospital surgery; pathogenesis of perioperative acute kidney injury; urine collection
pathogenesis of perioperative acute kidney injury
understand pathogenesis of perioperative acute kidney injury in elective and emergent surgery
urine collection
urine collection will be performed on both the control group and hospitalized participants
Healthy Control
Healthy Adult volunteers who are willing to provide a 200 ml urine sample.
urine collection
urine collection will be performed on both the control group and hospitalized participants
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pathogenesis of perioperative acute kidney injury
understand pathogenesis of perioperative acute kidney injury in elective and emergent surgery
urine collection
urine collection will be performed on both the control group and hospitalized participants
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned hospital stay of at least 24 hours
* Able to enroll prior to undergoing surgery
\> 18 years old that elect to serve as a control group
Exclusion Criteria
Renal Replacement Therapy AKI/CKD Nephrectomy Organ transplant
Any of the following within the last 12 months:
* Stroke/Transient Ischemic Attack
* Heart Attack
* Major Thoracic, abdominal, or Vascular surgery
* Radiation Therapy
* Chemo Therapy
* Immunosuppressive Therapy
IV contrast within the past 72 hours
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Azra Bihorac, MD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UF Health
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB201400127
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.